MUMBAI, India, May 9 -- Intellectual Property India has published a patent application (202517038713 A) filed by Pharmorage Pty Limited, Camberwell, Australia, on April 22, for 'modified oligonucleotides.'
Inventor(s) include Gantier, Michael; Laczka, Olivier; Wenholz, Daniel; Speir, Mary; and Sapkota, Sunil.
The application for the patent was published on May 9, under issue no. 19/2025.
According to the abstract released by the Intellectual Property India: "The invention relates to oligonucleotides that inhibit Toll-Like Receptor 7 (TLR7) and/or Toll-Like Receptor 8 (TLR8), or potentiate TLR8, and uses thereof."
The patent application was internationally filed on Oct. 12, 2023, under International application No.PCT/AU2023/051007.
Dis...